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CHAPTER I 
INTRODUCfiON 
Vanadate is reported to have insulin-like actions in diabetic rats. The anion 
lowers blood sugar in diabetic but not normal rats (Ramanadham, et al., 1989; 
Meyerovitch et al., 1987; and Heyliger et al., 1985). The initial response of blood sugar 
levels in diabetic rats with 0.8 mg/ml sodium vanadate added to drinking water requires 
several days, and occurs at a plasma concentration of 15-30 J.lM (Gil et al., 1988). Several 
metabolic actions of vanadate have been demonstrated in vitro using isolated cell systems 
or purified enzymes. Metabolic actions of vanadate in isolated hepatocytes and 
adipocytes from the rat often require very high concentrations of the anion compared to 
those effective in lowering blood sugar in the diabetic rat (mM versus JLM). On the other 
hand very low concentrations of vanadate are able to inhibit enzyme systems such as the 
Na+f K+ ATPase and phosphoprotein tyrosyl phosphatase activities. The actions of 
vanadate in diabetic rats could be related to a specific defect underlying diabetes, and the 
reversal of the diabetic state by vanadate may take long-term adaptation requiring 
regulation of gene expression. To address these problems, studies on the uptake of 
vanadate, and its actions on carbohydrate metabolism and enzymes involved in 
carbohydrate metabolism in hepatocytes from normal and diabetic rats maintained in 
short and long-term culture were carried out. In addition, to directly determine if vanadate 
regulates gene expression of hepatic pyruvate kinase, a chimeric gene construct of the 
1000 bp 5'-promoter region of the rat liver pyruvate kinase gene with firefly luciferase 
was transfected into primary cultures of rat hepatocytes and expression of the chimeric 
gene product was studied. 
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CHAF'fERII 
LITERATURE REVIEW 
Although vanadium is a trace element, it is distributed extensively in nature, and 
is present in almost all living organisms, including Man (Bhagavan, 1983). Vanadium 
was early recognized for it's ability to inhibit the activity of membrane Na+ I K +- ATPase 
(Table 1), however now various laboratories document this element is capable of 
affecting the activity of various intracellular enzyme systems and may modify their 
physiological functions Skou, (1965) as reported by Bhagavan et al., (1983). Vanadium 
was discovered by the Swedish scientist N.G. Sefstrom in 1830 and was named after the 
Scandinavian goddess "Freya Vanadis" ( Bhagavan et al., 1983). Bhagavan reported that 
the first researchers to conduct experiments on vanadium's biological properties were 
Gamyee and Larmuth, who studied the effects of the element on frog hearts in 1876. 
Jackson, observed that the pharmacological effects of vanadium were rather similar to 
those of digitalis (Bhagavan, et al., 1983). In 1977, Cantley and co-workers (Cantley et 
al., 1977) successfully purified from 'Sigma Grade' ATP a potent inhibitor of (Na+/K +)-
ATPase which was found identical with sodium orthovanadate (Na3 V04 ). 
Vanadium has been recognized as an essential nutritional requirement in higher 
animals for over two decades. Deficiency results in a general retardation of growth in rats 
(Bhagavan, et al., 1983) and the supplementation of vanadium in the diet (at subtoxic 
doses) leads to a variety of metabolic changes including disturbances in sulfur 
metabolism and cholesterol synthesis. 
2 
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TABLE 1 
MET ABOUC PROCESSES AND 
ENZYMES AFFECTED BY VANADATE 
PROCESS [EFFECTIVE VANADATE] 
IN VIVO 
Lower Blood Sugar 
in Diabetic Rats 
Isolated Cell Studies 
Stimulate Glycogen Synthase 
Stimulate Glucose Transport 
Stimulate Insulin Receptor 
Inhibit Gene Expression of 
Liver PEPCK in Hepatoma Cells 
Raise mRNA Levels for 
Liver Pyruvate Kinase 
in Rat Hepatocytes in Culture 
Isolated Enzyme Studies 
Inhibit Na+fK+ Stimulated ATP ase 
Inhibit P-Tyrosylphosphatases 
15-30 ~-&M 
0.2-l.OmM 
0.5-l.OmM 
4-.SOOnM 
REFERENCES 
Gil et al, (1990) 
Meyerovitch et al., (1987) 
Tamuraetal., (1984) 
Green et al., (1986) 
Mooney et al., ( 1989) 
Bosch et al., (1990) 
Montserat et al., (1991) 
Courtney et al. , ( 1978) 
Swarup et al., (1982) 
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Vanadium has a wide range of biological and biochemical effects; Bhagavan et al., 
(1983) reported vanadate's actions on the cardiovascular system (Schmitz et al., 1980), 
hypertension (Schroeder, 1957), and in manic depression Naylor et al., (1980). However, 
in relation to this thesis some of the most striking effects of vanadium are related to 
glucose metabolism, and it's insulin-like effects. Vanadate has been shown to inhibit 
several enzymes involved in carbohydrate metabolism, and has been reported as far back 
as 1979 to play a role in modifying blood glucose levels (Simons, 1979; Macara, 1980, 
and Singh, et al., 1981). 
Ramanadham et al., (1990) reported that this latter effect of vanadium was 
recorded many years ago when Lyonnet et al in 1899 observed that a small group of 
diabetic patients excreted less glucose in their urine when treated with sodium 
orthovanadate. In addition to being able to stimulate glucose oxidation (Dubyak and 
Kleinzeller 1980, Clark et al., 1985) , vanadium compounds are known to inhibit lipolysis 
(Curran, 1954; Snyder and Comatzer 1958) and to stimulate glycogen synthesis (Tamura 
et al., 1983). With the recognition of similarities between the physiological response to 
vanadium and insulin, vanadium compounds have been studied in the treatment of 
diabetic animals. The first demonstration of the effectiveness of vanadium in the diabetic 
animal was reported by Heyliger et al., (1985). In their studies, streptozotocin (STZ)-
diabetic rats were returned to euglycemic state after 6 weeks of oral vanadate treatment. 
Chemistry of Vanadium 
Vanadium, a group V element, (mol. wt. 50.9) belongs to the transition series and 
forms compounds in mainly valence states +3, +4, and +5. It readily changes its oxidation 
state. In the presence of oxygen, air, oxygenated blood or other oxidizing agents (e.g. 
diamide) vanadium is almost always in the +5 oxidation state irrespective of the nature of 
the original compound. Vanadium compounds are in the +4 oxidation state in the 
presence of reducing agents such as ascorbic acid. Furthermore vanadium can undergo 
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changes in charge depending on pH. Under physiological conditions at pH 7.4, vanadium 
in the +5 oxidation state is in the form of an anion vanadate (V04 3- or it's polyanions), 
while vanadium in the +4 oxidation state at this pH is predominantly in the cationic form, 
vanadyl (VQ2+). The +3 oxidation state is stable only in acidic solutions (pH less than 2), 
and in the absence of oxygen. At this pH the +5 oxidation state is prevalent as VQ2-, a 
blue vanadyl cation. Above pH 3, VO(OH)- begins to appear, followed by the dimer 
(VOOH)z2-and then above pH 4.5 by the formation of a precipitate of VO(OH)z. 
The +5 oxidation state is rather more complicated since although in acid it occurs 
as a dioxovanadium cation , VOz-. vanadate appears at physiological pH and above as 
anionic (HV042-) and tends to aggregate to polynuclear complexes. Vanadate also forms 
complexes with compounds possessing cis -glycol functions and with EDTA, and can 
form polynuclear species with phosphate. The close similarity of vanadate to phosphate 
accounts for much of its biological interest (Erdman et al., 1984). 
History of Diabetes 
The name diabetes mellitus was introduced by a first century Roman physician, 
based on the presence of sweetness in urine, the primary symptom of the disease 
(Koltermann, 1987). The initial concept of the disease was described as wasting of the 
body with the concomitant passage of large amounts of "sweet urine" leading to death 
over the course of a few weeks or months. In 1875, Bouchardat pointed out at least two 
clinical forms of the disease existed in man, one form typically occurring in young 
individuals who were underweight, and the second form predominant in obese adults. 
The pancreas became the focus of attention in diabetic research when it was discovered 
in the late 1800's that pancreatomy in dogs produced the disease. This concept was 
strengthened by the discovery and isolation of insulin by Banting and Best in 1921 
(Koltermann, 1987). Himsworth and Kerr introduced the concept of resistance to the 
action of insulin in the mid-1930's. The introduction of radioimmunoassay for insulin in 
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the 1960's soon produced evidence that many adult-onset diabetics had high levels of 
insulin and, in fact responded to oral glucose loads with insulin levels in excess of those 
seen in normal individuals. 
Classification of Diabetes mellitus 
The National Diabetes Data Group set forth a system of classification in 1979 that 
was described to improve the precision with which both physicians and investigators 
describe diabetic patients. These are as follows; 
1. Spontaneous diabetes mellitus (90% )of cases. 
a) Type I, insulin dependent diabetes ( IDDM). 
b) Type II, non-insulin dependent diabetes ( NIDDM). 
2) Secondary diabetes. 
a) Pancreatic disease. 
b) Excess counter-regulatory hormones. 
c) Drug-related or drug-induced. 
d) Hyperglycemia associated with complex genetic syndromes. 
3. Impaired glucose intolerance. 
4. Gestational diabetes: Glucose intolerance that appears during pregnancy. 
5. Previous abnormality of glucose intolerance that has apparently returned to normal. 
It is Type II (NIDDM) that is of major importance because it is observed in nearly 
80% of diagnosed patients (Bergman and Best, 1989). In contrast to type I diabetics, who 
are usually lean, Type II diabetics are often obese (Koltermann, 1987; Doniach, et al., 
1983, and Olefsky et al., 1981). Obesity is such a prominent feature of Type II diabetics 
that some experts maintain that diabesity would be a more appropriate name for the 
disorder. Although over 90% of Type II diabetics exhibit positive family histories for 
diabetes, the linkage between genetic mechanisms and pathogenesis of the diabetic state 
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is not as evident as it is in Type I diabetes. In contrast, insulin deficiency is irreversible in 
the Type I diabetic (Koltermann, 1987). 
Cellular insulin action is initiated by the interaction of the hormone with specific 
cell surface receptors. As a result of the interaction, a signal or signals are generated that 
activates the various effector mechanisms required to express insulin effects. The 
molecular weight of the insulin receptor is approximately 350, 000. The receptor consists 
of two a-subunits (MW 135, 000 each) and two ~subunits (MW 90, 000). Both subunits 
of the receptor are glycoproteins, with the glycosidic moieties located on the external 
surface of the cell. The bulk of the ~-subunit is probably located within the plasma 
membrane, whereas the major portion of the a-subunit is exposed to the extracellular 
space (Koltermann, 1987). Insulin binds to the a-subunit, and this binding event results in 
the phosphorylation of the ~-subunit. This phosphorylation of insulin receptor initiates a 
cascade of cellular phosphorylation reactions, resulting in signal transmission to diverse 
effector mechanisms, which include both membrane processes and multiple enzymatic 
processes. Therefore, a defect in any step in this cascade of events required for the 
expression of insulin's cellular effects could theoretically lead to an insulin-resistant state. 
The molecular basis of Type II diabetes is still poorly understood despite 
intensive research. Elevated blood glucose levels in diabetics is the consequence of 
reduced uptake of glucose by muscle and adipose tissues, and enhanced synthesis of 
glucose by the liver. In addition, diabetes causes the change in gene expression of 
enzymes critical in the regulation of carbohydrate metabolism. Also, diabetes is 
accompanied by enhanced phosphorylation of these regulatory enzymes. One of these 
enzymes , Type L pyruvate kinase (Blair et al., 1976; James and Blair, 1982; Miyanga et 
al., 1982; Munnich et al., 1984 and Blair, 1985), is regulated by insulin both through 
phosphorylation and at the level of gene expression. 
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The Insulin-Mimetic Fffects of Vanadate 
Most tissues of higher animals contain intracellular vanadium at a concentration 
of 0.1-1.0 uM (Simons, 1979). A new interest in vanadium emerged when vanadate was 
demonstrated to mimic the action of insulin in hexose uptake and glucose metabolism in 
rat adipocytes (Dubayak, and Kleinzeller, 1980; and Shechter and Karlish, 1980) Some 
of the other known effects of vanadate are shown in Table 1. The low molecular weight 
of vanadate and it's analogy to phosphate seems to enable vanadate to permeate plasma 
membranes and the intestinal wall with relative ease. This can occur by either passive 
diffusion or by means of an anion carrier. This fact led to Heyliger et al., (1985) attempts 
at oral treatment of vanadate in diabetic rats. Oral administration of insulin is ineffective. 
In their studies high dose streptozotocin-treated rats were used as an animal model 
because it reflects symptoms of both Type I and Type II diabetes. These rats exhibit low 
production of insulin and high levels of circulating glucose. The rats were catabolic, 
insulin-target tissues such as fat, liver, and muscle exhibit insulin resistance in spite of 
increased levels of insulin binding. Heyliger et al., ( 1985) used a 4.34 mM Na3 V04 
solution containing 80 mM NaCI in the drinking water, which had been shown to reduce 
toxicity. The treatment resulted in the reduction of blood glucose levels and the 
elimination of depressed cardiac performance. The therapy did not increase the levels of 
endogenous insulin, therefore insulin target tissues were implicated as the sites of 
vanadate action (Heyliger et al., 1985). 
After Meyerovitch et al., (1987) documented that the conditions utilized by 
Heyliger and colleagues led to hypoglycemia, Shecter et al., (1988) found that sodium 
meta vanadate (Na V03) at a concentration of 1.63 mM was the optimal dosage. They 
found that lower concentrations (0.65 mM) were ineffective. Vanadate solutions were 
replaced with freshly prepared solutions every 3 days and applied to streptozotocin-rats 
one week after the induction of diabetes. This resulted in a reduction to normal levels of 
blood glucose concentration. This effect was reversible. After replacing vanadium 
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solution with drinking water which contained only 80 mM NaCl, normoglycaemia 
persisted for another 15 -20 hours after which hyperglycemia recurred. 
In addition Shecter et al., (1988) discovered that streptozotocin rats were catabolic 
in nature (i.e. lost 1g/day) became anabolic by vanadate therapy. The average daily 
weight gain amounted to + 1.25 g/rat. The rate of hexose uptake in vivo was elevated. 
They showed that vanadate therapy doubled the rate of 3-0-methyl glucose uptake in 
muscle and liver tissues for control and streptozotocin-rats (Sheeler et al., 1988). Thus the 
normoglycaemia observed in vanadate treated streptozotocin-rats seemed to result from 
vanadate stimulation of glucose uptake and it's metabolism in vivo, in agreement with 
known actions of vanadate in in vitro systems. Schecter et al. further documented that 3 
wk treatment of ST-rats with 1.63 mM NaV03 did not raise serum levels of urea, 
creatinine, and glutamic-oxaloacetic transaminase. Moreover, low vanadate treatment 
lowered elevated urea levels in streptozotocin-rats to control values. They concluded that 
several weeks of low vanadate treatment does not result in impairment of renal hepatic 
functions. They also stated that there might be overlapping site(s) of actions for both 
vanadate and insulin, and because the insulin receptor is an insulin available tyrosine 
specific protein kinase, and vanadate is an inhibitor of phosphotyrosine phosphatase, an 
overlapping site might be a putative endogenous substrate that it's tyrosine 
phosphorylation and dephosphorylation turns on and off insulin-dependent bioprocesses. 
In 1988, Levy et al. reported that diabetic animals responded to vanadate 
treatment in two ways. Streptozotocin rats with their corresponding controls were treated 
orally with sodium metavanadate. A gradual increase of the vanadate concentration up to 
6.55 mM in the drinking water lowered the blood glucose levels of the diabetic animals to 
normal values without changing the insulin levels. On the other hand, vanadate did not 
affect the blood glucose levels of the non-diabetic animals, it did however induce lower 
levels of circulating insulin in these animals. The lowering of the glycemic values of the 
diabetic animals was closely related to the consumption of vanadate. In addition while the 
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large majority of the diabetic animals displayed stable nonnoglycemic values others had 
fluctuating values. They proposed that the lowering of the blood glucose levels may be 
due to the stimulation of glucose uptake, glucose stimulation, and glycogen synthesis 
elicited by the presence of high levels of circulating vanadium. The levels of circulating 
insulin remained low in the vanadium treated diabetic rats which indicates that the 
lowering of the glycemic values was probably due to changes in glucose metabolism. 
Vanadate treated control animals showed low levels of insulin. They proposed that these 
results seemed to indicate that vanadate treatment, by stimulating glucose uptake, and 
metabolism, mimic the action of insulin and consequently may reduce its secretion. 
However, the accumulation of lipid droplets found in the acinar cells of non-treated 
diabetic animals were reduced after vanadate treatment (Ramanadham et al., 1989). This 
may be due to a lowering of blood glucose levels and simulation of glucose utilization. 
Furthermore, they stated that the levels of circulating non-essential fatty acids were also 
restored with the lowering of the glucose levels by vanadate, and concluded that this was 
probably related to the reported action of vanadate in stimulating glucose incorporation 
into lipids in adipocytes and increase in hepatic glycogenesis (Fantus et al., 1989). 
In most experiments carried out by researchers investigating the insulin-like 
effects of vanadium, the element was in the +5 oxidation state as vanadate. However, 
Ramanadham et al., (1990) reported enhanced in vivo sensitivity of vanadyl-treated 
diabetic rats to insulin. Their study was designed to investigate the concentration-
dependent effects of oral vanadyl treatment and possible in vivo interaction of vanadyl 
with insulin in the diabetic animal. While blood glucose levels were affected by all 
concentrations of vanadyl, 3.4 mM and 4.5 mM produced earlier and greater responses 
with more consistent decreases. The differential effects on blood glucose were observed 
though vanadyl intake reached similar levels in all groups. They speculated that the in 
vivo level of vanadyl had to reach a threshold level before the effects started, hence very 
high concentrations (3.4 mM-4.5 mM) of vanadyl in the drinking water was required. 
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Furthermore, they noted that because vanadium is rapidly excreted by the kidneys 
(Hudson, 1964), lower concentrations of vanadyl promotes a more pronounced diuresis 
and thus a greater elimination of vanadium because it is consumed in larger volumes. 
Ramanadham also stated acute administration of submaximal doses of insulin, 
which was usually only marginally effective in untreated diabetic rats lowered blood 
glucose levels in vanadyl-treated and vanadyl-withdrawn diabetic animals to near control 
values within 1 hour. They concluded that treatment of diabetic animals with vanadyl 
somehow enhanced peripheral tissue sensitivity to insulin, therefore lower endogenous 
circulating levels of insulin or smaller doses of exogenously administered insulin were 
required. This was supported by Chaliss et al., (1987) who demonstrated enhanced in 
vitro sensitivity of soleus muscle to insulin, isolated from control animals treated for 2 
weeks with vanadate. Their finding also agreed with reports of decreased circulating 
levels of insulin in control animals while the levels in diabetic rats remained low after 
chronic treatment with vanadium (Heyliger et al., 1985; Ramanadham et al., 1989). The 
combination therapy was next attempted in spontaneously diabetic rats. The animals, 
which absolutely depend on insulin for survival were initially maintained in a control 
state with daily administrations of insulin (9-13 U/kg) for 14-30 days. Inclusion of 
vanadyl (0.25 mg/ml) in the drinking water resulted in a gradual decrease in the dosage of 
insulin (about 4 U/ kg) required to maintain the rats nonglycosuric. Neither this minimal 
dose of insulin nor vanadyl (0.25 mg/ml) alone was found to be sufficient in glycosuria 
by themselves. Animals remained healthy and gained weight even though the insulin dose 
was reduced more than 30%. These results provided further evidence of an enhancement 
of the in vivo effects of insulin in the presence of vanadyl (Ramanadham, 1990). 
Vanadate Modulation of Rat Liver Pyruvate Kinase 
Pyruvate kinase catalyzes (EC 2.7.1.40) the final committed step of glycolytic 
metabolism in mammalian tissues. 
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Pyruvate kinase ..,. 
Phosphoenolpyruvate+ MgADP Mg2+,K+ Pyruvate + MgA TP 
The presence of elevated pyruvate kinase activity in the liver following high 
carbohydrate meals is consistent with the lipogenic capacity of this tissue in most species 
(Hopkirk and Bloxham, 1979). However, functional pyruvate kinase activity will result in 
recycling of phosphoenolpyruvate to pyruvate representing a loss of gluconeogenic 
capacity to the liver (Katz and Rognstad, 1976). Pyruvate kinase is a unique isozyme, 
which has kinetic and allosteric properties suited to its position in hepatic carbohydrate 
metabolism. For example, Tanaka et al., ( 1967) demonstrated that the enzyme is induced 
in response to high carbohydrate diet and insulin. In 1976, Blair et al., showed that 
pyruvate kinase was acutely regulated by glucagon and insulin. These and later 
observations showed that pyruvate kinase plays an extremely important role in hepatic 
carbohydrate regulation (Blair, 1981). The present discussion focuses on recent advances 
concerning the regulatory properties of pyruvate kinase in diabetes with emphasis on the 
modulation of L-type pyruvate kinase gene expression by vanadate. 
Isozymes of Pyruvate Kinase 
(Tanaka et al., 1967~ Harada et al., 1978~) reported that there are four isoenzymes 
of pyruvate kinase in mammals, M1, M2, L, and R. Type M2 pyruvate kinase is 
predominant in the internal organs such as spleen, lung, and kidney. Type M1 is found in 
adult skeletal muscle and is a major isozyme in heart and brain. Type R pyruvate kinase 
is found in erythrocytes. Type Lis the major isozyme of adult liver and the only isozyme 
found in the parenchymal cells of this tissue in adults (van Berkel et al., 1972~ Crisp and 
Pogson, 1972; Garnett et al., 1974). In the rat, type L pyruvate kinase appears in the fetal 
liver approximately 7 days before birth and the activity rises rapidly until birth (Saheki et 
al., 1978). Its expression is regulated developmentally, and expression is also regulated 
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transcriptionally by insulin and glucagon (Noguchi et al., 1985; Thompson and Towle, 
1991). The rat liver pyruvate kinase gene is composed of 12 exons and 11 introns with a 
length of about 9.3 kilobase pairs (Noguchi et al., 1987). The first (exon R) and the 
second (exon L) exons encode the 5'-terminal sequences specific to the R-and L types 
respectively, while the remaining downstream exons are common to the two enzymes. 
Promoter sequences are present in the upstream region of exon R and exon L, 
respectively indicating that the L- and R-type isozymes of rat pyruvate kinase are 
produced from the liver pyruvate kinase gene by the use of different promoter sequences. 
(Yamada etal., 1990). 
Studies by Maniatis et al., (1987) indicated that the control of gene expression is 
achieved through the interactions between cis-acting DNA elements and trans-acting 
proteins that bind to these DNA sequences. cis-Acting DNA elements responsible for cell 
type specific and hormonal regulation of gene expression have been identified (Maniatis 
et al., 1987; and Roesler et al., 1988). Most of these elements are located in the 5'-
flanking region of the gene. 
As mentioned earlier, rat L-type pyruvate kinase (L-PK) gene belongs to the 
category of genes whose expression is induced after feeding a diet rich in carbohydrate. 
The increase in pyruvate kinase enzyme activity is due a corresponding change in liver 
pyruvate kinase mRNA levels that result from an increased rate of gene transcription 
(Vaulont et al., 1986). Induction of liver pyruvate kinase by carbohydrates requires 
insulin, although both insulin and carbohydrate are required for induction, it appears in 
the case of the liver pyruvate kinase gene that insulin is not the direct effector, but plays a 
permissive role by stimulating highly insulin-dependent steps of glycolysis (Mariash et 
al., 1981). Conversely glucagon can inhibit liver pyruvate kinase gene expression, 
possibly by reducing glycolysis (Vaulont et al., 1986). When both insulin and glucagon 
are present the effect of glucagon is dominant (Thompson and Towle, 1991). In order to 
investigate the induction of liver pyruvate kinase gene expression by carbohydrate, 
14 
Thompson and Towle (1991) used a transfection system involving cultured primary 
hepatocytes. Decaux et al., (1989) demonstrated that primary hepatocytes showed an 
increase in liver pyruvate kinase mRNA levels when cultured in the presence of high 
glucose or fructose concentrations, thus providing a useful system for studying 
carbohydrate regulation of gene expression. Thompson and Towle prepared sequences 
from the 5'-flanking region of the liver pyruvate kinase gene, which were tested for their 
ability to direct carbohydrate-stimulated expression of the reporter gene Chloramphenicol 
acetyl transferase, (CAT) after transfection into primary hepatocytes. They showed that 
expression of the transfected L-PK ( -197) CAT construct correlated with expression of 
the endogenous liver pyruvate kinase gene under all conditions tested. Thompson and 
Towle, (1991) eventually localized the carbohydrate response element of the rat liver 
pyruvate kinase gene to the region between -197 and -96. These 101 base pairs are 
necessary for glucose-stimulated expression of the pyruvate kinase gene and are 
sufficient to confer carbohydrate responsiveness to the promoter. This was consistent 
with the work of Yamada et al., ( 1990) who identified three positive regulatory elements 
designated as LPK-1, LPK-11, and LPK-111 in the upstream region of the cap site for the 
L-type isozyme of the liver pyruvate kinase gene. These elements which have synergistic 
effects on homologous promoters, are necessary for hepatocyte-specific expression of the 
LPK gene., and are located in the first intron of the liver pyruvate kinase gene, between 
exon R and exon L. The similarity of the responses of both the endogenous and 
transfected genes to insulin and glucagon, as well as both glucose and fructose, suggested 
that alterations in the liver pyruvate kinase promoter activity are primarily responsible for 
controlling production of liver pyruvate kinase mRNA (Thompson and Towle, 1991). 
Miralpeix et al., (1991) showed that vanadate in the presence of glucose raises 
mRNA levels of L-PK gene. They used the same experimental procedure as described by 
Decaux et al .• (1989). After 5 days of culture in the presence of 10 mM glucose and 10 
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nM insulin, the cells were cultured for 24 hours in a medium containing lactate but no 
glucose or insulin. Hepatocytes were then cultured for 24 hours in the presence of 10 JJ.M 
vanadate with or without glucose plus insulin. When hepatocytes were cultured for 24 
hours with vanadate plus lactate in the absence of glucose, after deprivation of glucose 
and insulin, no accumulation of liver pyruvate kinase mRNA was observed. Glucose 
alone was insufficient in stimulating the expression of liver pyruvate kinase gene mRNA 
levels where raised only when glucose and vanadate were present together, as occurred 
with insulin plus glucose. However the increase of liver pyruvate kinase mRNA levels in 
the presence of vanadate plus glucose was much less than that observed with insulin plus 
glucose. The accumulation of liver pyruvate kinase mRNA in the presence of insulin plus 
glucose in vitro was less than 10% of that reached in vivo and even lower when insulin 
was replaced by vanadate (Miralpeix et al., 1991). 
The reaccumulation of liver pyruvate kinase mRNA in the presence of glucose 
plus vanadate or glucose plus insulin was totally blocked by the addition of 50 JJ.M cyclic 
adenosine monophosphate (cAMP). This inhibitory effect of cAMP was not counteracted 
by glucose plus vanadate or glucose plus insulin, as had been shown in refed animals 
(Vaulont et al., 1986). Miralpeix et al., (1991) concluded that vanadate acts similarly to 
insulin on gene expression, and that the vanadate-glucose-dependent increase of liver 
pyruvate kinase levels also could depend on the presence of a transcriptional activator 
derived from carbohydrate metabolism and accumulated in the presence of vanadate plus 
glucose. 
Characterization of Vanadium Uptake 
Very little work has been carried out to date on the rate of vanadate uptake and or 
release of vanadate by cultured cells. Vanadate is taken up by cells through the anion 
carrier although non-specific uptake may occur (Nechay et al., 1986). In short-term 
culture systems (1-6 hours), high concentrations of vanadate may be required to obtain 
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biological responses due to a slow uptake mechanism, thus requiring higher 
concentrations of the ion in order to achieve sufficient amounts into the cell. Limited 
uptake may occur since vanadate appears to be taken into cells by an anion carrier, which 
can be inhibited by phosphate. In living cells, vanadate is reduced to vanadyl by 
intracellular reducing agents like glutathione (Macara et al., 1980). However, it is often 
not possible to restrict experiments concerning biochemical or biological aspects of 
vanadium to one single species, especially when whole cells or organs are involved. For 
example, in experiments with cultured erythrocytes, vanadium is usually added as 
vanadate, because only this anion is thought to be able to cross the plasma membrane of 
such cells (Nechay et al., 1986). Uptake is followed by slow intracellular reduction of 
vanadate to vanadyl so that both compounds will be present in the cells. Therefore its 
difficult to ascribe an observed action to a certain vanadium specie (Bode et al., 1990). 
CHAPTER III 
MATERIALS AND METHODS 
Cell Preparation 
Isolated hepatocytes were prepared from male Wistar rats (200-300g) obtained 
from Charles River Laboratories, Wilmington, MA, and fed Purina 5001 Rat Chow, by 
collagenase (40 mg of Worthington Type II Lot# 48E294F) digestion of a perfused liver, 
previously described (Bonney et al., 1974; Kleitzen et al., 1976) by Blair et al., (1976) 
The rats were anesthetized with pentobarbital (50 mg/kg or 0.1 ml./100g body/wt., 
intraperitoneal). The liver was surgically extracted and hooked up via the hepatic portal 
vein to a cannula which allowed the perfusion media, filter sterile calcium-free Krebs 
Ringer Bicarbonate, KRB (200 ml of 0.9% NaCl, 8 ml of 1.15% KCI, 1.5 ml of 2.11% M 
KH2P04, 1.5 ml of 3.82% MgS04.?H20, 42 ml of 1.3% NaHC03, and 0.1 ml of 400 
mg/ml streptomycin sulfate 37°C, 5% COz, 95% 02, pH 7.4, Krebs and Henseleit, 1932 
as reported by Berry et al., 1991) to recirculate for approximately 20 minutes, or until the 
liver was completely digested. After digestion, the liver was removed from the perfusion 
system and minced in 50 ml of cold perfusion media, and passed through 4 layers of 
cheesecloth. The resulting suspension of isolated hepatocytes was made up to 100 ml 
with more perfusion media, gassed with a stream of 5% C02, 95% 02, and centrifuged 
and resuspended with cold perfusion media three times to remove dead cells and other 
debris. Cell viability was determined by a lactate dehydrogenase assay which measured 
the loss of LDH from the cells thus indicating cell rupture. A high percentage of lactate 
dehydrogenase in the solute signified cell rupture, and any cell preparation which had less 
than 50 % enzyme recovery in the cells was terminated. 
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Vanadium Analysis 
Preparation of Sodium orthovanadate 
Purified grade Na3 V04 (Fisher Scientific) was used in all experiments. A 0.1 M 
stock solution was prepared by dissolving solid Na3 V04 in 0.1 M HEPES buffer. This 
gave a colorless solution with a pH of 10. It has been reported that at this pH vanadate is 
predominantly monomeric as HV042- (Bernier, et al., 1988). The final concentration of 
vanadate solutions was verified by measurement of absorbance at 260 nm using an 
extinction coefficient of 3.55 x 1Q3 M-1 cm-1 (Bernier et al., 1988). Immediately before 
each experiment an aliquot of a freshly prepared stock was diluted into the cell culture 
medium. 
Quantification 
The cell samples and 0.5 ml of the media samples were pipetted into 15x75 mm 
test tubes, and placed in heating blocks at 1 00°C. They were oxidized by adding 1 part 
concentrated nitric acid, and 1 part concentrated hydrogen peroxide (H202). 100 JA.l of 
H202 was added repetitively to all tubes until the last one was completely oxidized, 
evidenced by a clean tube or the remains of white flaky material at the bottom of the tube. 
The samples were then ashed in a Muffle Furnace at 300°C for 45 minutes, diluted in 
0.5% Nitric acid, Vanadium was then measured by atomic absorption of the element on 
an Epson Equity III+ Computer controlled Perkin llmer 5100 Zeeman Atomic Absorption 
Spectrophotometer. Ashing and analysis steps of this procedure were kindly performed 
by Dr. Barbara Stoecker of the Department of Nutritional Sciences. The amount of 
vanadium was read against standards supplied by Inorganic Ventures, Toms River, NJ., 
and normalized with the DNA content. 
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DNA Analysis 
DNA content of the cells was quantified using a modified Burton Assay (1956). 
The cells were scraped off the plates and 200 JA.I samples (stored in 66% ammonium 
sulfate, 30 mM 2-mercaptoethanol) used for the assay. To remove endogenous 
deoxynucleotides I deoxynucleosides, and the ammonium sulfate, the samples were spun 
down in a microcentrifuge tube at 1000g for 4 minutes. The supernatant was decanted, 
and the pellet redissolved in 500 JA.l of 5% trichloroacetic acid (fCA), centrifuged again 
and the supernatant discarded. The samples were incubated at 700C for 15 minutes in 600 
JA.I of 10% perchloric acid (PCA), and .500 JA.I of the resulting supernatant was transferred 
to a clean tube containing 500 JA.I of 4 % diphenylamine in acetic acid, and 25 JA.l of 0.4% 
acetaldehyde, mixed well sealed, and incubated at 300C for 16 hours. Absorbance was 
determined at 595 nm and calf thymus DNA used as a standard. Each condition was 
carried out in triplicate. 
Metabolic Experiments 
Isolated hepatocytes were pipetted in 1ml aliquots into gassed, stoppered 
scintillation vials, and incubated in a 37°C shaking water bath for 30 minutes. As required 
the vials contained different concentrations of nutrients and hormones as indicated; 
sodium orthovanadate, glucagon, and 10 mM dihydroxyacetone. Each experiment was 
terminated by the addition of 50 JA.l of 70% perchloric acid. Glucose and lactate levels 
were analyzed using standardized methods described below. 
Glucose Analysis 
Fifty JA.l of concentrated (70%) perchloric acid was added to 1 ml cell samples, 
allowed to sit overnight, and the transferred into 15 x 75 mm test tubes. Each sample was 
centrifuged at 1000 r.p.m. for 10 minutes and 50 JA.l of the solute added to 2 ml of 
glucostat reagent. Standards were prepared by pipetting in duplicate 0, 10, 25, 50, and 
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100 Ill of a 3.0 mM glucose solution into test tubes containing 2 ml of glucostat reagent. 
The samples and the standards were vortexed well and the absorbance at 600 nm was 
read after 1 hour on a Gilford rapid sampling spectrophotometer. 
Lactate Analysis 
The lactate assay buffer was made by mixing 47 ml of 1.0 M glycine and 38 ml of 
hydrazine sulfate together and adjusting the pH to 9.2 with NaOH. After the final volume 
was brought up to 100 ml with water, 78 mg of NAD+, and 50 Ill of 10 mg/ml LDH 
enzyme (Sigma) was added. 100 Ill of the sample were transferred to a tube containing 
900 !!I of the lactate buffer, and incubated at room temperature for 1 hour. A blank was 
prepared by adding 100 J.ll of water to 900 J.ll of buffer. Absorbance at 340 nm was 
measured on a Gilford rapid sampling spectrophotometer. 
Enzyme Analysis. 
Isolated rat hepatocytes from male Wistar Rats (200-300g) were prepared as 
previously mentioned, and diluted to approximately 800 ml with Swims S-77 (Gibco, 
BRL), in a sterile 1 liter plastic conical flask, gassed and stored on ice. Ten ml of cells 
were pipetted on to rat-tail collagen coated 100-mm tissue culture plates. The cells were 
incubated at 37°C, and 5 % COz. 95% 02, and allowed to attach for a period of 4 hours. 
After the initial attachment phase, the media was poured off, and replaced with fresh 
media containing different concentrations of sodium orthovanadate, low glucose (5.5 
mM), or high glucose (25 mM), and 10 nM insulin which was used as a positive control. 
At this point three plates were removed and used as a "zero time point control". The 
experiments were terminated after 36 hours by pouring off the media and replacing with 5 
ml of cold 66% ammonium sulfate containing 30 mM 2-mercaptoethanol (Foster and 
Blair, 1978). The plates were stored at 4°C. The cells were scraped from the plates and 
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centrifuged at 2,500g for 4 minutes. The pellet was resuspended in 500 !AI of 66% 
ammonium sulfate containing 30 mM 2-mercaptoethanol. 
Pyruvate Kinase <PK) Assay 
50 !AI of the cell sample was mixed well with 750 !AI of PK Buffer (pH 7.4) in a 
cuvette. The buffer consisted of 10 ml of 0.4 M Tris-CI , 5 ml of salt stock (2 M KCI and 
1M MgS04), 400 !AI of NADH (10 mg/ml, Sigma), and 25 ~AI lactate dehydrogenase (10 
mg/ml, Sigma) and 2.5 ml of 15% Triton X-100. The reaction was started by the addition 
of25 "'I of the substrate mix (100 mM ADP, 100 mM PEP and 10 mM FBP). PK activity 
was determined spectrophotometrically by the disappearance of NADH at 340 nm and 
300C according to Foster and Blair ( 1978). 
Lactate Dehydrogenase <LDH) Assay 
5-10 ~AI of cell sample was mixed with 1 ml of LDH Buffer (50 ml of 0.4 M Tris-
Cl, 10 ml of 10% Triton X-100, and 40 ml of water, pH 7.4) containing 20 !AI of NADH 
(10 mg/ml). The reaction was started by the addition of 25 !AI of sodium pyruvate (40 
mg/ml), and change in the absorbance of NADH at 340 nm and 3o:>C was determined 
(Foster and Blair, 1978). 
Other Reagents 
Glucagon 
Stock solutions of glucagon were prepared by dissolving 1 mg of glucagon (Lilly 
Research Laboratories) in 1 ml of water. One t~l aliquots of 1 M HCI were added until the 
glucagon completely dissolved, i.e. when the solution became clear. The final 
concentration was determined by measuring the absorbance at 278 nm using an extinction 
coefficient of 8.31 mM-1. Stock solutions were stored at 4°C, and diluted to required 
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concentrations in media containing BSA which prevents absorption of glucagon on glass 
surfaces. 
Insulin 
Stock solutions were achieved by dissolving 1 mg of crystalline porcine zinc 
insulin (Lilly Research Laboratories) in 1 ml of lmM HCJ, and the concentration 
determined spectrophotometrically at 276 nm using E 0.1%/1 em = 1.05. Aliquots of the 
stock were further diluted as required in media containing bovine serum albumin. 
Transient Transfection 
Chimeric Gene Constructs 
GenelightTM plasmids (Promega) provide a basis for the quantitative analysis of 
gene expression. They carry the coding region for firefly (Photinus pyralis) luciferase 
which is used to monitor transcriptional activity in transfected cells. Each Genelight 
plasmid carries the Juciferase gene (luc) followed by the SV40 T antigen intron and 
polyadenylation Poly (A) signals. A second copy of the poly (A) site, located upstream of 
the Juciferase coding region limits background transcription from spurious promoters in 
the plasmid. The vectors also contain a prokaryotic origin of replication for maintenance 
in E. coli , an ampicillin -resistance gene for selection, and a filamentous phage origin of 
replication (fl ori) for single stranded DNA production. Restriction sites for insertion of 
DNA fragments are located upstream and downstream of the luciferase gene. Two of the 
upstream sites (Xhoi and Bgl II) yield cohesive ends compatible with the downstream 
sites (Sal I and Bam H I respectively), allowing the interchange of the DNA insert for 
rapid analysis of positional effects. The Genelight plasmids were pGL2 Basic, pGL2 
Promoter, and pGL2 Basic which had the 5'-promoter region of the pyruvate kinase gene 
inserted in front of the Juciferase gene. 
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The 5'-promoter region of rat liver pyruvate kinase representing approximately 
1000 bp upstream from the start site for transcription of the LPK gene was obtained by 
polymerase chain reaction amplification of genomic DNA by Dr. Raul Espinosa-Nava 
(personal communications). The regulatory 5'-3' region sequence was obtained from 
Vaulont et al., (1986) and synthetic oligonucleotides were made as polymerase chain 
reaction primers. 
5' [Hind III]ATGGTATGAT ... .3' (2166 position) Hind III end= GGAAGCTI 
3'TCTGTGTCGTCCA TTCG[Bgl II) 5' (3204 position) Bgl II end= TCTACA GGTIC 
The promoter was inserted into a plasmid containing the coding region of firefly 
luciferase (Promega) per instructions of the supplier. 
Transfection 
Isolated hepatocytes from fed or starved male Wistar Rats (200-350g) were 
prepared as previously mentioned. The cells were diluted to high density (about 5 ml of 
packed cells were made up to 600-650 ml in the incubation medium (Table 2). Six ml of 
cells were pipetted onto rat-tail collagen coated tissue culture plates (60-mm), and 
incubated for 4 hours. The lipofection method described by Ponder et al., (1991) was 
used for transfection. After the initial attachment phase, the media was aspirated off using 
a sterile Pasteur pipette and the cells washed twice with 2 ml of phosphate buffered 
saline, then 2 ml of transfection media (Table 2) was added. 20 f.ll of Lipofectin 1 mg/ml, 
(Gibco, BRL ; Gaithersburg, MD), was mixed well in a polystyrene tube with I f.lg of 
DNA, which had previously diluted in 20 f.ll of sterile water. Genelight Basic + Reg 5 
plasmid (containing a PK promoter) was used for the experiments. A positive control 
pGL2 inserted with an SV40 promoter, and a negative control pGL2 Basic Promoter-less 
plasmid were also used. The DNA/Lipofectin complexes were incubated for 15 minutes 
at room temperature then 40 f.ll added dropwise to each plate. 
TABLE2 
TRANSFECfl ON AND INCUBATION MEDIA 
Ingredient Amount per liter 
Incubation media Transfection media 
Minimum &sential Medium (Sigma) 75/J ml 
Waymouth (Gibco) 25/J ml 
Bovine Serum Albumin 2g 
Alanine 40mg 
Serine 52.6 mg 
Penicillin G 60mg 
Streptomycin sulfate 100mg 
Fungi zone 0.25mg 
Insulin 1 mg 
Glutamine 292mg 
Human Growth Hormone (2.4 IU/mg) 250 1-'1 
Dexamethasone 
3, 5, 3'- triiodo-L-thyronine,T 3 ( 1 mg/ml) 
75/J ml 
25/J ml 
40mg 
52.6mg 
251-'l 
0.78mg 
6731-'1 
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After 16 hours in a 5% C02 incubator maintained at 37°C, the medium was aspirated and 
replaced with fresh transfection media supplemented with effectors as specified. The cells 
were maintained in culture for another 12-24 hr. Experiments were terminated by 
aspirating off the media, and freezing plates at -20°C. 
Luciferase Assay 
A reporter system in which firefly luciferase activity was measured to determine 
the level of expression of transfected PK. The cells are lysed with a Lysis Reagent 
(Promega) to release the reporter protein luciferase. Both A TP and the substrate luciferin 
were added to the lysate in a luminometer. The enzyme catalyzed a rapid, A TP-dependent 
oxidation of the substrate, which then emits light. Total light output was measured and is 
proportional to the amount of luciferase present over a wide range of enzyme 
concentrations (Brasier et al., 1989 and Williams et al., 1989). 
The Luciferase Substrate (Promega) was dissolved in 10 ml of Luciferase Assay 
Buffer (Promega). Dilute 1 volume of the cell culture lysis reagent, 5X (Promega) with 4 
volumes of water to produce a lX stock. The cells were thawed, incubated at room 
temperature for 15 minutes in 250 Ill of lx cell culture lysis reagent, scraped into 
microcentrifuge tubes, and centrifuged for 5 seconds to pellet debris. Luminescence was 
read on a m<Xlel 2010 A Lumac luminometer, using 40 Ill of the extract. The assay was 
linear over a wide range beyond that found in the liver extracts as demonstrated using 
purified luciferase supplied by Dr. Franklin Leach. 
CHAPTER IV 
RESULTS AND DISCUSSION 
Vanadate Accumulation in Rat Hepatocytes 
Vanadium accumulation in isolated rat hepatocytes was studied to estimate the 
concentration in the cells after long and short term exposure to the anion. This was 
carried out to see if the levels of vanadium accumulated by rat liver hepatocytes 
correlated with the concentrations necessary for its actions on carbohydrate metabolism, 
and gene expression. In order to do this several assumptions were made: 1) Each plate or 
vial contained the same amount of cells, 2) The carry over of vanadate at the termination 
of each experiment is negligible, and 3) The vanadium measured in the cell pellet was 
mainly intracellular. Due to the large cell/media volume ratio, there were also difficulties 
in measuring the cell volumes accurately. Short and long term exposures were initiated 
because these time frames covered the time needed for vanadium to exert it's effects on 
glucose metabolism, change in enzyme activity, and gene expression. 
Short-term Experiments 
Isolated hepatocytes were incubated in 50 ml of incubation media containing 
different concentrations of sodium orthovanadate (Na3 V04). The flasks were gassed with 
5% C02, 95% 0 2 every 30 minutes and kept stoppered while rotating in shaking water 
bath (at 37<>C) for the duration of the experiment. At 60, 120, and 240 minute time 
intervals 1ml aliquots were removed, and centrifuged at 10, OOOg for about 10 sec. 0.5 ml 
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of the supernatant and the whole pellet were kept for vanadium analysis. This was carried 
out in triplicate for each concentration of vanadate at that particular time point. A similar 
experiment was done using 1mM vanadate, and shorter time points. The volume of cells 
in these experiments was determined before addition of the incubation media , and was 
assumed to remain constant over the incubation period. 
Table 3 shows that the uptake of sodium orthovanadate in short-term cultured 
hepatocytes occurred rapidly. Extracellular vanadium concentration over these periods of 
time also showed a significant decrease. Vanadate rapidly accumulated to approximately 
the same concentration as the extracellular media, and at high ( 1 mM) concentrations this 
occurred as early as 15 minutes or earlier. All the vanadium was accounted for by adding 
up the amount of vanadium in the cells and the media at the end of each experiment and 
seeing if it was essentially the same as the total vanadium in the original media. 
Long-term Experiments 
These experiments were carried out over a 12-24 hour time period. Isolated 
hepatocytes were plated on rat-tail collagen coated 100-mm Coming tissue culture plates. 
They were incubated for an initial attachment period of 4 hours in a 5% C~, 95% Oz 
water jacketed incubator set at 37°C. After this the media was decanted off and replaced 
with fresh media containing different concentrations of vanadium. The experiment was 
stopped at 12 and 24 hours by pouring off the media and washing the cells with cold 
isotonic saline. The saline was decanted and the plates and media were frozen at -20°C 
for subsequent analysis. A control was achieved by exposing the cells to vanadate and 
immediately stopping the experiment as mentioned above. The cells were then thawed 
and scraped from the plates with the aid of a 'rubber policeman', and transferred into 
15x75 mm test tubes. Cells cultured for longer periods of time in 10 uM vanadate showed 
a significant increase in intracellular vanadate (Table 4). 
TABLE3 
SHORT -TERM UPTAKE OF VANADIUM BY FRESH ISOLA TED 
RAT HEPATOCYTES 
Experiment I 
Condition Media Cells Total 
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nmoles [Vanadate] J.LM nmoles [Vanadate] J.LM V nmoles 
Original media 23.5±1.8 46.3±3 NM NM 23 
No vanadate 0.0±0* 0.0±0* 0.0±0* 0.0±0* 0 
Zero min. 23.6±0.6 47.2±1.2Z 0.0±0* 0.0±0* 23 
60min. 16.8±0.5 33.5±Q.9X 1.5±0.2 65.3±7.8C 19 
120 min. 19.5±0.3 38.9±0.6Y 1.2±0.01 48.3±0.4b 21 
180min. 22.0±0.5 43.9±0.9Y 0.9±0.1 39.9±2.1a 23 
Ex~riment II 
Time (min.) Media Cells Total 
J.tmoles [Vanadate] mM f.Lmoles [Vanadate] mM V f.Lmoles 
Original 0.35±0.03 0.70±0.05 NM NM 0.35 
No Vanadate 0.0±0* 0.0±0* 0.0±0* 0.0±0* 0 
zero 0.19±0.05 0.37±Q.lQX 0.16±0.01 1.3±0.1 a 0.35 
15 0.25±0.05 0.50±0.02Y 0.16±0.01 1.3±0.1a 0.41 
30 0.24±0.01 0.47±0.()9Z 0.16±0.01 1.3±0.1a 0.40 
45 0.28±0.02 0.55±Q.Q3Z 0.17±0.04 1.4+0.3a 0.45 
60 0.24±0.05 0.47±0.1 ()Z 0.17±0.02 1.4±0.2a 0.41 
*Vanadium was measured but was not detectable 
NM= Not measured 
The amount of sodium orthovanadate taken up by cells exposed to different 
concentrations of the anion is presented as the mean ±S.E.M. of three determinations for 
each condition Numbers with the same letter are not significantly different. p < 0.01. 
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TABLE4 
VANADIUM UPTAKE BY LONG-TERM PRIMARY CULTURE RAT 
LIVER HEPA TOCYTES 
Condition Media Cells 
[Vanadate] !.l M mgONA nmoles V Estimated 
per Elate per Elate [Vanadate] JAM 
Experiment I 
No Vanadate 
0 h ND* 0.12±0.01 NO* ND* 
12 h 0.03±0.01 0.12±0.01 NO* ND* 
24h 0.06±0.02 0.11±0.02 ND* ND* 
0 h 9.1±0.1 0.10±0.01 0.5±0.1 S±P 
12 h 7.7±0.2 0.12±0.01 1.05±0.01 8±1 b 
24h 6.8±0.03 0.12±0.02 1.99±0.10 16±5C 
0 h 167±3 0.11±0.03 4.9±0.5 45±7d 
12 h 161±2 0.10±0.02 7.4±0.2 68±7C 
24h 147±17 0.11±0.01 10.7±0.1 9Q±5f 
Experiment II 
No Vanadate ND* ND* ND* ND* 
1 !.lM Vanadate 
Oh 1.5±0.1 0.12±0.02 ND* ND* 
18h 1.6±0.2 0.09±0.01 0.12±0.03 2±0.1 a 
36h 1.7±0.5 0.09±0.01 0.13±0.03 2±0.43 
10 !.lM Vanadate 
Oh 9.9±1.7 0.10±0.03 ND* ND* 
18h 7.5±0.4 0.10±0.01 0.4±0.1 5±2b 
36h 6.5±0.6 0.09±0.02 0.8±0.2 11±3C 
* ND= Vanadium was measured but not detectable 
Vanadate accumulation in rat liver hepatocytes exposed to different concentrations of 
vanadate is presented as the mean± S.E.M. n=3. Numbers with the same letter are not 
significantly different. p < 0.01 
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At 12 hours the concentration had equilibrated with the media. At higher concentrations 
(167 ~M) the cellular content still did not attain high amounts, but reached levels close to 
the media concentration. 
Regulation of Carbohydrate Metabolism by Vanadate 
Isolated hepatocytes from fed and fasted male Wistar rats were pipetted in lml 
aliquots into gassed, stoppered scintillation vials, and incubated in a 37°C shaking water 
bath for 30 minutes. As required the vials contained different concentrations of sodium 
orthovanadate, glucagon, and 10 ~M dihydroxyacetone. 
Experiments were performed to analyze: 
1) Glucose and lactate production from endogenous glycogen in fed rats, (Table 
5) in response to increasing concentrations of glucagon, without vanadate, and in the 
presence of lmM vanadate. Vanadate resulted in a shift in the glucagon dose response 
curve. The magnitude of the response of the cells to glucagon was the major effect, and 
lmM vanadate lowered glucose output from endogenous glycogen in all concentrations 
of glucagon, and in the control. Vanadate was also capable of overcoming the inhibition 
of lactate formation by glucagon in fed animals. Table 5 shows that the effect of vanadate 
became significant at around a glucagon concentration of 1 ~M. 
2) Glucose and lactate production from 10 mM dihydroxyacetone in isolated 
hepatocytes treated with different vanadate concentrations, with and without glucagon. 
from 18 hour fasted rats. In these types of experiments the rats were fasted because its 
been demonstrated that the levels of glycogen in fasted rats are extremely low, therefore 
any glucose produced by the end of the 30 minute experiment came from 
gluconeogenesis via dihydroxyacetone, an added substrate. This enabled me to follow the 
glycolytic I gluconeogenic pathway in both directions, the formation of glucose and the 
opposite way, the formation of lactate. A vanadate dose curve (Figure 1) shows that 
increasing the concentration of the anion reduced glucose production in control cells, but 
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the effect was more pronounced in hepatocytes given I J.LM glucagon. The anion was able 
to raise lactate production to control levels in rats incubated in 1 J.LM glucagon (Figure 2), 
until the vanadate concentration reached 1mM, when lactate production had fallen 
drastically. 
Table 6 shows that 100 J.LM vanadate was able to significantly reduce glucose production 
in both control and 1 J.LM glucagon treated cells. As in the fed animals, glucagon did not 
increase the cells sensitivity to vanadate, but just increased the magnitude of response. 
Cells exposed to glucagon produced more glucose than the control cells exposed to the 
same concentration of vanadate. Lactate production was significantly increased by 50 J.LM 
vanadate in both control and glucagon treated cells. 
TABLE5 
EFFECT OF 1 mM VANADATE ON GLUCOSE AND LACTATE PRODUCTION IN FED RATS IN RESPONSE TO 
INCREASING CONCENTRATIONS OF GLUCAGON 
[Glucagon] M Glucose Production Lactate Production 
~moles I ml packed cells ~moles /ml packed cells 
No Vanadate 1 mM Vanadate No Vanadate 1 mM Vanadate 
0 11.64±0.64a 3.43±0.47f 11.86±0.29i l2.66±0.37i 
}()-10 15.43 ±l.08b 3.45±0.91 f 11.59±0.41 ij 11.59±0.22j 
3xto-to 16.75±0.5QC 4.23±0.43 fg 11.18±0.25j 11.39±0.21 jk 
1()-9 17.83±0.41 d 428±0.34fg 11.07±0.10j 10.99±2.12k 
I0-8 17.92±0.20d 5.30±0.99h 10.40±0.15k 10.59±l.08k1 
lQ-6 21.J7±4.25C 5.77±0.65h 8.28±0.651 10.18±0.791 
Glucose and lactate production in isolated hepatocytes incubated at 37°C for 30 minutes, from a fed rat. 
Results represent the mean ±S.E.M. of triplicate conditions in at least three experiments 
Numbers with the same letters are not significantly different. p < 0.01 
w 
t-> 
Figure 1. The Effect of Vanadate on Glucose Synthesis from 10 mM Dihydroxyacetone. 
' Glucose production in fresh hepatocytes over a 30 minute incubation 
period at 37°C was determined as described in the Material and Methods is 
plotted versus increasing concentrations of sodium orthovanadate. The 
cells were incubated for 30 minutes at 37 °C. Each point represents the 
mean :::t: S.E.M. of triplicate conditions. Similar results were obtained in at 
least two separate experiments. 
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Figure 2. The Effect of Vanadate on Lactate Production From 10 mM Dihydroxyacetone 
Lactate production in fresh hepatocytes over a 30 minute incubation 
period at 37°C was determined as described in the Material and Methods is 
plotted versus increasing concentrations of sodium orthovanadate. The 
ceHs were incubated for 30 minutes at 37°C. Each point represents the 
mean ± S.E.M. of triplicate conditions. Similar results were obtained in at 
least two separate experiments. 
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TABLE 6 
THE EFFECT OF VANADATE ON LACTATE FORMATION AND GLUCOSE PRODUCTION 
FROM 10 mM DIHYDROXY ACETONE BY 1 ~-tM GLUCAGON 
IN FRESH HEPATOCYTES FROM STARVED RATS 
Glucose Production Lactate Production 
~-t moles /ml packed cells ~-trnoles I ml_packed cells 
No Glucagon 1 ~-tM Glucagon No Glucagon 1 ~-tM Glucagon 
7.94±0.13 y J1.05±2.6QX 1.10±0.01 a 0.92±0.0la 
8.13±0.48Y 10.99±0.39X 1.12±0.04a l.06±0.02a 
7.78±0.44Y 10.32±0.46X 1.64±0.04a 1.46±0.09a 
6.71±0.43Y 9.91±1.2T'l 2.03±0.04b 1.98±0.Q8b 
611±0.74Z 8.64±0.89Y 2.07±0.()6b 2 06±0.()6bc 
5.88±Q.Q7Z 7.86±0.83Y 2.20±0.08 b 2.27±0.22bc 
4.08±0.23P 7.28±0.18Y 2.24±0.Q5C 2.29±0.02C 
The effect of different concentrations of vanadate on glucose and lactate formation from 10 mM dihydroxyacetone by isolated 
hepatocytes incubated at 37°C for 30 minutes, from starved rats was presented as means ±S.E.M. of triplicate conditions, in at least 
two separate experiments. Numbers with the same letter are not significantly different. p < 0.01 
VJ 
VI 
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The Effect of Vanadate on Pyruvate Kinase Activity 
Although vanadate regulates carbohydrate metabolism, and lowers blood glucose 
levels in diabetic rats Gil et al., (1988), and Meyerovitch et al., (1987), the effect at the 
lower concentrations takes longer . Therefore isolated hepatocytes were cultured for up to 
36 hours to determine the effect of the anion on carbohydrate metabolism in long term 
culture. However, due to the changes that occur over long term culture, measuring the 
production of metabolites as carried out in short term experiments would have been more 
complicated. For example, glycogen accumulates which may interfere in the 
interpretation of results of the analysis of other metabolites. Changes in enzyme levels are 
easy to measure, and controls are simple to obtain, therefore enzymatic studies were 
initiated to find out the effect of vanadate on carbohydrate metabolism in relation to 
pyruvate kinase, a key regulatory enzyme in glycolysis. This enzyme was also chosen 
because Montserat et al., (1991) reported that levels of vanadate as low as 25 JIM were 
capable of raising mRNA levels of pyruvate kinase. Experiments were set up to 
determine the effect of 10. 50, and 100 JIM sodium orthovanadate, and 10 nM insulin in 
the presence of physiological (5.5 mM) and diabetic (25 mM) levels of glucose on 
pyruvate kinase activity in cells cultured for 36 hours (Table 7). Relatively high 
concentrations such as lmM vanadate previously used in the metabolic studies were 
dropped because they were observed to have an adverse effect on cell viability over the 
extended time periods used in primary culture. Table 7 shows the results of these 
experiments. 10 JIM vanadate significantly increased PK activity as did 50 JIM and 100 
JIM concentrations of the anion. 
TABLE7 
THE EFfECT OF VANADATE ON PYRUVATE KINASE ACTIVITY 
IN CULTURED RAT HEPATOCYTES 
Condition 
Control 
10 nM Insulin 
10 "'M Vanadate 
50~-' M Vanadate 
100 ~-' M Vanadate 
PK Activity units/mg/DNA 
5.5 mM Glucose 25 mM Glucose 
6.3±1.68 7.5±1.4ab 
9.2±0.9b 8.5±0.6ab 
25.1±7.0d 36.2±5.5e 
12.2±1.3bc 18.0±3.1 c 
13.2±1.3bc 13.0±1.4bc 
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The effect of insulin, and different concentrations of vanadate on pyruvate kinase activity 
in isolated rat hepatocytes in primary culture for 36 hours. The table shows the mean 
±S.E.M. of triplicate conditions, repeated in at least three experiments. Numbers with the 
same letter are not significantly different p < 0.01. 
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Vanadate Induction of Liver Pyruvate Kinase Gene Expression 
Although Table 7 shows that vanadate raised pyruvate kinase activity in cultured 
liver hepatocytes, the data wasn't able to prove whether the increase in enzyme levels 
came from increase in actual protein activity, or a change in messenger levels due to a 
modulation of gene expression. To directly assess gene expression, gene constructs 
containing a 1000 base pair 5'-region of the pyruvate kinase promoter at the 5' end of the 
firefly luciferase gene were transfected into isolated hepatocytes in the presence of 
different concentrations of vanadate, insulin, and glucagon. Due to the fact that the 
transfection system is very sensitive to DNA concentration, this parameter had to be 
optimized by varying the amount of plasmid DNA put on each plate (Table 8), to 
ascertain the concentration that produced the most light ( Relative Light Units, RLU). 
The amount of Lipofectin was kept constant at 20 1'1 per plate, since smaller quantities 
produced no transfection at all (data not shown). A linearity test was also carried out to 
determine if light units produced fell within the proportional range of the luciferase assay 
(Figures 3 and 4). The cells were incubated for 24 hours after transfection. Tables 9 and 
10 show that insulin, vanadate, and glucagon increased gene expression of the pyruvate 
kinase promoter region under investigation. Table 9 shows that 10 I'M vanadate had the 
greatest effect, while 10-6M insulin was the concentration of the hormone that produced 
the most significant increase in gene expression. Lower concentrations of vanadate were 
still capable of raising PK gene expression levels (Table 10), with the response occurring 
at concentrations as low as 0.25 J'M, in the presence of high (25 mM) glucose. 
A glucose dose curve was set up to analyze whether the effects of vanadate and 
glucose were additive or synergistic (Table 11). From the results vanadate and glucose 
probably work in a synergistic manner. In all experiments two sets of controls were 
included. A blank, the promoter-less plasmid which never produced a relative light unit 
value of more than 11, and the positive control SV40. This plasmid indicated whether the 
transfection worked each time. 
TABLES 
OPI'IMIZA TION OF THE DNA CONCENTRATION REQUIRED FOR 
TRANSFECTION 
DNA (f.lg) RLU 
0.00 
0.50 
0.75 
1.0 
2.0 
3.0 
4.0 
24h post transfection incubation 
139±4.0b 
232±18C 
9±()a 
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Expression of pyruvate kinase gene in isolated hepatocytes incubated for 24 hours after 
transfection in 25 mM glucose and 10-6 M insulin. DNA amounts were varied to find the 
optimum amount for maximum light production. The data is presented as means± S.E.M. 
n=3. Numbers with the same letter are not significantly different. p < 0.01. 
Figure 3. Linearity of Luciferase Assay using Liver Cell Extracts. 
Light emission (RLU) in the standard luciferase assay was determined 
using increasing amounts of extract (0, 10, 20, and 40 ul) from liver cells 
transfected with pGL2 plasmid containing liver pyruvate kinase promoter 
exposed to 25 mM glucose and I0-7 M insulin to test linearity of the 
assay. Details of the luciferase assay are provided in the Materials and 
Methods. Similar findings have been noted in several tests for linearity of 
the assay 
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Figure 4 Lucifemse Standard Curve. 
40 J.ll of different concentrations of purified luciferase (Sigma) were 
assayed according to methods described in the Material and Methods 
section to determine whether light emission (RLU) was proportional to 
the amount of luciferase in the assay. 
41 
700 -/ .. 
600-
----- RlJ 
/ 
/ 
/ 
/ 
500- / 
/ 
/ 
400- / 
:;I 
/~ ~ 300- / ./ 
200- // 
.// 
100-v. 
0 ... 
... I I I I 
0 1 2 3 4 5 
[Luciferase] 10"16 M 
42 
TABLE9 
MODULATION OF PYRUVATE KINASE GENE EXPRESSION IN ISOLA TED RAT 
HEPATOCYTES BY VANADATE, INSULIN, AND GLUCAGON 
Condition 
Control 
10-8M Insulin 
10-7M Insulin 
1Q-6M Insulin 
1Q-IOM Glucagon 
3x1Q-10M Glucagon 
10-7M Glucagon 
11.1. M Vanadate 
S1.1.M Vanadate 
10 1.1.M Vanadate 
SV40 
Promoter-less plasmid 
10 mM Glucose 
9±JX 
133±11 d 
106±7cd 
115±6cd 
62±5b 
58±4ab 
126±700 
90±1800:1 
56±2b 
103 ±3 00 
not tested 
not tested 
RLU 
25 mM Glucose 
24±3a 
136±2Jd 
188± 52e 
244±15ef 
72±6bc 
59±6ab 
111±5cd 
342±25g 
224±26e 
418±5h 
247±10* 
9±0* 
The effect of different concentrations of insulin, glucagon, glucose, and vanadate on the 
expression of pyruvate kinase gene in isolated hepatocytes 24 hours after transfection 
with plasmids containing a region of the pyruvate kinase promoter in front of firefly 
luciferase gene. Data represents mean± S.E.M. of triplicate conditions. Similar responses 
were observed in at least two separate experiments. Numbers with the same letter are not 
significantly different. p < 0.01. 
* In other experiments glucose and insulin have no effect on the SV40 plasmid (data not 
shown) and the promoter-less plasmid. 
TABLE 10 
VANADATE AND INSULIN REGULATE PYRUVATE KINASE GENE 
EXPRESSION IN RAT LIVER HEPATOCYTES 
Addition RLU 
10 mM Glucose 25 mM Glucose 
Control 137±28bc 183±28C 
0.25 1.1. M Vanadate 172±23C 221±I8d 
0.50 1.1.M Vanadate 223±28d 260±27C 
1.00 1.1.M Vanadate 206±25cd 276±25e 
2.00 1.1. M Vanadate 192±15cd 282±27C 
5.00 1.1.M Vanadate 186±45C 362±53g 
10.0 1.1.M Vanadate 219±46cd 218±26cd 
IQ-6M Insulin 155±25bc 435±26h 
10-7M Insulin 135±22ab 337±22f 
10-8M Insulin 101±25ab 264±2}C 
1o-9M Insulin 73±6a }87±35c 
IO-lOM Insulin 142±45bc 163±31 be 
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The effect of low concentrations of vanadate, and insulin on pyruvate kinase gene 
expression 24 hours post-transfection in isolated rat hepatocytes exposed to two levels of 
glucose. Data represents mean± S.E.M. of triplicate conditions. Numbers with the same 
letter are not significantly different. p < 0.01. 
Addition 
Nothing 
lQ-6 M Insulin 
1 ll M Vanadate 
5 ll M Vanadate 
Dihydroxyacetone 
Fructose 
Glycerol 
* Not determined. 
TABLE 11 
THE EFFECT OF VANADATE, INSULIN, INCREASING GLUCOSE CONCENTRATIONS 
AND CERTAIN SUGARS ON PYRUVATE KINASE GENE EXPRESSION. 
RLU 
lOmM 20mM 25mM 30mM 40 mM 
Glucose Glucose Glucose Glucose Glucose 
358±}9C 659±44e 753±105ef 722±51 ef 717±23ef 
487±27d 871±55g 805±84S 1233±20 i 735±41 ef 
730±44ef 983±30h 1139±54i 1004±551!h 1128±158ih 
662±70e 1017±33Sh 686±55e 770±97ef 926±131! 
295±34b * * * * 
289±22b * * * * 
145±3ta * * * * 
The effect of increasing concentrations of glucose, on pyruvate kinase gene expression in the presence of vanadate, and insulin, and 
dihydroxyacetonc, fructose, and glycerol. Data shows the mean of triplicate conditions ± S.E.M. Numbers with the same letter arc not 
significantly different at p < 0.01 
t 
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Discussion 
Measurements of vanadate levels in the blood (Meyerovitch eta/., 1987) and liver 
(Gil et al., 1990) of diabetic rats given low oral doses of sodium vanadate to lower blood 
sugar indicate that 15-30 J.LM vanadate is an effective concentration eliciting insulin-like 
actions on the intact rat. Although not directly measured, these studies indicate that 
vanadate is not concentrated to high levels in the liver. Tables 1 and 2 show that vanadate 
is not accumulated to high concentrations in isolated liver hepatocytes; rather the anion is 
taken up by cells until the intracellular concentration approximates that in the media. In 
rat liver hepatocytes the uptake of vanadate occurs rapidly, since cellular concentration 
reached extracellular range within 15 minutes. Longer term exposure in primary cells 
cultured in various concentrations of vanadate did not result in a concentration of the 
anion . These findings with liver contrasts with reports in yeast (Bode et al., 1990) and 
erythrocytes (Nechay et al., 1986). The accumulation of high amounts of vanadate in 
yeast cells appear to be due to vacuoles trapping the anion (Bode et al., 1990). In 
erythrocytes vanadate appears to be reduced to vanadyl ion which is accumulated to high 
amounts. Therefore, liver may be distinct from these other specialized cells with regard to 
vanadate uptake and concentration. The importance of the present findings is that 
metabolic pathways influenced by vanadate in the liver result in lowered blood sugar, and 
therefore the liver must be sensitive to low concentrations of the ion if it is to reflect the 
situation in intact animals responding to vanadate. 
Vanadate lowers blood glucose in diabetic rats (Meyerovitch et al., 1987; 
Heyliger et al., 1985; and Gil et al., 1990). The anion may accomplish this by reducing 
glucose production in the liver either from glycogenolysis or gluconeogenesis. Results in 
this study show that vanadate inhibits glucose production in the liver from the 
aforementioned pathways. In hepatocytes from fed animals incubated without exogenous 
substrates vanadate lowers glucose production and counteracts the effect of glucagon 
(Table 5). High conentrations of vanadate such as 1mM are more effective and shifts the 
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glucagon dose response to the right. However the effects at high concentrations may be 
due to the toxic actions of the anion. Vanadate also inhibited glucose production from 
dihydroxyacetone in starved rats. In both types of experiments 50-100 !-1M vanadate were 
the lowest doses capable of producing a response. These levels are likely too high to 
account for the insulin-like actions of vanadate in diabetic rats. 
Long term incubation of isolated hepatocytes with vanadate resulted in an 
increase in pyruvate kinase activity (Table 7). This indicates that the anion exerts effects 
on the cells that cause longer term adaptation in enzymes of carbohydrate metabolism. 
Table 7 shows that 10 JA.M vanadate significantly increased pyruvate kinase activity in 
cells cultured for 36 hours. Higher concentrations of the anion did not appear to work as 
well, possibly due to the toxic actions of higher concentrations of the anion. It appears 
that glucose enhances response to 10 JA.M vanadate. The concentration at which vanadate 
was most effective fell within the range capable of raising pyruvate kinase mRNA levels 
reported by Miralpeix el al., (1991), and Montserat et al., (1991), and with the 
observation that glucose enhances this response. 
Having ascertained that vanadate increases pyruvate kinase activity in cultured 
hepatocytes, the next step was to assay for the regulation of promoter expression. Table 9 
shows that vanadate was capable of inducing pyruvate kinase promoter expression in 
liver cells over a 24 hour incubation period. One, five, and ten JA.M vanadate significantly 
raised chimeric PK gene promoter expression in moderately high ( 10 mM), and very high 
(25 mM) glucose levels. The controls were a group of cells which were not exposed to 
insulin, vanadate, or glucose. There was a combined effect between glucose and vanadate 
because 25 mM glucose significantly increased gene expression under all conditions .. 
Concentrations of vanadate as low as 0.5 JA.M were found to significantly increase L-PK 
promoter expression. These effective concentrations are similar to those observed to raise 
PK mRNA levels (Miralpeix et al., 1991). The lowest glucose concentration used in the 
present experiments was approximately 10 mM, because the incubation media contained 
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25% Waymouth which is rich in glucose (27 mM). Therefore, gene expression at 
physiological levels was not achieved in this study. Additional experiments utilizing 
media containing physiological, or no glucose are needed in the future to clearly define 
the role of the sugar. The other sugars dihydroxyacetone, glycerol, and fructose (all at a 
concentration of 15 mM) appeared ineffective. Thompson and Towle, (1991) reported 
that fructose increased pyruvate kinase promoter gene expression, but they used insulin 
their studies. 
In the enzyme and gene expression experiments, insulin was used as a positive 
control. Although the hormone did not appear to raise pyruvate kinase activity in culture 
it did significantly increase pyruvate kinase chimeric gene expression especially in the 
presence of glucose (Tables 9 and 10). This dichotomy in insulin action was probably due 
to the sensitivity of the luciferase assay, and the rapid metabolism of insulin by the liver 
cells. Also in enzyme studies pyruvate kinase is initially present in the cells at significant 
concentrations. Therefore changes in enzyme activity are imposed on top of the initial 
level. In the gene expression experiments the cells do not normally produce luciferase, 
therefore any change is more easily measured. Insulin had a greater effect on gene 
expression in the presence of high levels of glucose, which is consistent with Thompson 
and Towle, ( 1991). These are effects that are more consistent with the insulin-like actions 
of vanadate and should be focused on in the future. 
Glucagon did not give the results anticipated. Glucagon is reported to inhibit gene 
expression of pyruvate kinase in transfected hepatocytes (Thompson, and Towle, 1991), 
however Table 9 shows that the hormone induced expression. Thompson and Towle, 
(1991) used a chimeric construct containing at least 4000 bp of the 5' promoter region, 
while we used only a 1000 bp region. Additional chimeric constructs need to be 
developed to study glucagon actions and to identify the precise regions within the 1000 
bp pyruvate kinase promoter region that are regulated by vanadate. 
CHAPfERV 
SUMMARY AND CONCLUSIONS 
Vanadate has several insulin-like actions in isolated rat hepatocytes. The ability 
of the anion to inhibit glucose synthesis and to stimulate glycolytic formation of lactate in 
fresh hepatocytes require high concentrations of the anion and may be related to toxic 
actions of vanadate. However, in fresh hepatocytes, lower concentrations of vanadate 
appear to have some selective reversal in glucagon actions, suggesting a specific non 
toxic effect of the anion. Longer term incubation of hepatocytes from starved rats is 
accompanied by increased concentrations of the glycolytic enzyme pyruvate kinase, 
suggesting an action of the anion on gene expression. These responses were observed 
with vanadate concentrations as low as 0.5 -10 J.LM which corresponds to circulating 
levels of the anion capable of lowering blood glucose concentrations in diabetic rats. This 
phenomenon could be due to the effect of vanadate increasing the rate of transcription of 
pyruvate kinase, which stimulates glycolysis. Further studies need to be carried out to 
determine the exact location of the pyruvate kinase gene promoter that is modulated by 
vanadate. 
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